With the identification of stem cell plasticity several years ago, multiple reports raised hopes that tissue repair by stem cell transplantation could be within reach in the near future. Krause et al reported that a single purified hematopoietic stem cell not only repopulated the bone marrow of a host animal, but also integrated into unrelated tissues. Lagasse et al demonstrated that in a genetic model of liver disease, purified hematopoietic stem cells can give rise to hepatocytes and rescue fatal liver damage. More recent work by Jiang et al demonstrated that cultured cells can retain their stem cell potential. There are a number of possible mechanisms that could explain these phenomena, and recent experiments have raised controversy about which mechanism is prevalent. One possibility is transdifferentiation of a committed cell directly into another cell type as a response to environmental cues. Transdifferentiation has been shown mainly in vitro, but some in vivo data also support this mechanism. Direct transdifferentiation would clinically be limited by the number of cells that can be introduced into an organ without removal of resident cells. If bone marrow cells could on the other hand give rise to stem cells of another tissue, then they could in theory repopulate whole organs from a few starting cells. This model of dedifferentiation is consistent with recent data from animal models. Genetic analysis of cells of donor origin in vivo and in vitro has brought to light another possible mechanism. The fusion of host and donor cells can give rise to mature tissue cells without trans-or dedifferentiation. The resulting heterokaryons are able to cure a lethal genetic defect and do not seem to be prone to give rise to cancer. All these models will clinically face the problem of accessibility of healthy primary cells for transplantation. This underlines the importance of the recent identification of a population of mesenchymal stem cells (MSCs) with stem cell properties similar to embryonic stem (ES) cells. These cells can be cultured and expanded in vitro without losing their stem cell potential making them an attractive target for cell therapy. Finally, it is still not clear if stem cells for various tissues are present in peripheral blood, or bone marrow and thus can be directly purified from these sources. Identification of putative tissue stem cells would be necessary before purification strategies can be devised. In this review, we discuss the evidence for these models, and the conflicting results obtained to date. 
In brief Progress
In vitro analysis demonstrates that real transdifferentiation surmounting the germ layers is possible Dedifferentiation from a mature cell to a stem cell remains controversial Spontaneous cell fusion occurs in vitro and in vivo Not all conversion of bone marrow to other cell types is the result of fusion Cells with properties similar to ES cells reside in adult tissues Tissue stem cells may circulate in the adult organism
Prospects
Cell fusion may not be deleterious, and could be used for therapy Culture of stem cell populations will allow to screening for viral insertion sites to avoid oncogene activation after transduction Understanding the process of in vitro transdifferentiation will allow generation of mature tissues for transplantation Tissue stem cells will be identified and purified for expansion and transplantation overexpressing keratinocyte growth factor in the pancreas. In an in vitro assay using a pancreatic cell line, AR42J-B13, foci of hepatic cells could be induced by exposure to the synthetic glucocorticoid dexamethasone. [1] [2] [3] [4] Further, dexamethasone can induce hepatic differentiation in the pancreatic bud of a normal mouse embryo and its effect is mediated by C/EBP-b. Transdifferentiated cells expressed albumin, glucose-6-phosphatase and amylase. Residual GFP protein, which had been expressed from the elastase promoter specific for mature exocrine cells, demonstrated that these albumin-producing cells were derived from fully differentiated exocrine cells. In a further study Jang et al 5 purified a cell population with hepatic potential from mouse bone marrow. Bone marrow cells were elutriated, depleted of mature cells, homed to the bone marrow in primary hosts, recovered and then transferred into Transwell plates. These wells allow the exchange of soluble factors, but no direct contact between two populations of cells. When liver tissue, which had been damaged by the hepatotoxin carbon-tetrachloride (CCl 4 ), was placed in the second chamber, up to 2.5% of the bone-marrow derived cells matured into a hepatic phenotype expressing albumin, CK18, GATA4, HNF4, TDO and cytochrome P450.
These examples demonstrate that a change of cell identity or fate is possible if the right environmental cues are given to a cell in vitro. How much inherent plasticity a cell can demonstrate, how far transdifferentiation can go and which cell types retain this ability remain to be clarified.
Dedifferentiation from a mature cell to a stem cell remains controversial Direct transdifferentiation is thought to give rise to a differentiated cell without generating an intermediate tissue stem cell (Figure 1 ). In the lung, some experiments suggest a different mechanism. 6 The high level of engraftment observed in this organ could be linked to damage induced by whole-body irradiation used as part of the bone marrow transplantation protocol. Histological signs of tissue damage in the lung are first present on day 3 and are countered by proliferation and repair first apparent on day 5. From this time point on, donorderived type II pneumocytes could be shown by fluorescence in situ hybridization (FISH) with probes specific for the Y chromosome and by in situ hybridization of RNA. The percentage of marrow-derived type II pneumocytes increased over time from 0.9 to 13% by month 6. As type I pneumocytes are progeny of type II pneumocytes the latter are regarded as the tissue stem cell for the lung parenchymal epithelium. The authors argue that dedifferentiation of a bone marrow cell to an epithelial stem cell must have occurred to explain these results.
LaBarge and Blau 7 studied the dedifferentiation of a bone marrow cell into a muscle stem cell, and from there to mature muscle fibers. The authors show that cells from the bone marrow integrate into muscle tissue in two distinct stages. First, the irradiation used for the bone marrow transplant clears the tissue stem cell niche from the native satellite cells, followed by repopulation from bone marrow-derived cells. The engrafted cells express markers of satellite cells (cMet-R and Myf-5) and are phenotypically indistinguishable from native satellite cells in situ (Figure 2a ). After this stage cells contribute to the muscle mass by creating muscle fibers, albeit at a low level which could be increased by a training regimen for the mice (from 0.2 to 3.5% donor nuclei). Exercise induces damage to intracellular and membrane components of the muscle, and satellite cells respond to this environment by becoming mitotic and fusing with the muscle tissue. When bone marrow-derived satellite cells were isolated to high purity from the muscle these cells were able to self-renew and produce muscle fibers in vitro. Furthermore, when injected into the tibialis Gene therapy progress and prospects K Kashofer and D Bonnet anterior (TA) muscle of experimental mice, they again contributed to the muscle tissue in the secondary recipient. No gross abnormalities were found in the karyotype of these cells, indicating that a bone marrow cell has successfully adopted an unrelated stem cell phenotype. Camargo et al 8 sorted side population (SP) cells from mouse bone marrow and introduced these into host animals. Upon successful bone marrow engraftment, muscle damage was induced by repeated injections of cardiotoxin into the TA muscle on one side of the animal. Analysis of the injured and the noninjured muscle revealed donor-derived nuclei only in muscle fibers of the injured side. However, even with extensive analysis of the muscle fibers, the authors were unable to find donor-derived satellite cells in sections of the muscle, by flow cytometry or after isolation of all satellite cells in an in vitro assay of myotube formation. Instead the authors demonstrated that a cell of the macrophage lineage is the main contributor to donor myotubes in this model, likely attracted by the inflammation caused by the toxin used to induce tissue damage. Regardless of the mechanism for fusion in muscle fibers, one further problem is gene expression from the donor nucleus after the integration.
Lapidos et al 9 demonstrate that integration of donor nuclei into fibers of the skeletal muscle or cardiomyocytes was not an efficient method to rescue the lack of delta-sarcoglycan in a knockout mouse model.
Spontaneous cell fusion occurs in vitro and in vivo
In an attempt to generate pluripotent stem cells in vitro from adult bone marrow, Terada et al established cocultures with embryonic stem cells. After 7 days of coculture, puromycin was added to the culture medium to eradicate the supportive embryonic stem cells. A surviving cell fraction was obtained, which expressed markers of the donor animal (GFP and puromycin resistance) but exhibited the proliferation rate of embryonic stem (ES) cells and also the expression of ES cell markers (Oct3/4 and UTF1). These cells could successfully be differentiated into various lineages similar to embryonic stem cells. However, subsequent DNA analysis showed that all 13 cell lines derived with this protocol had more than diploid DNA content, and microsatellite analysis revealed genomic content from both mouse strains used in the coculture. 10 In a related study Yiang et al 11 initiated clonally derived free-floating neuronal stem cell cultures (neurospheres) from dissociated forebrains of ROSA26 fetuses and cocultured them with ES cells. After selection, they demonstrated frequent generation of hybrids showing genomic markers of both mouse strains used. Interestingly, upon introduction into a blastocyst, these cells contributed to the intestine, kidney, heart and most prominently the liver. 12 Cell fusion was also shown in a model of coculture of small airway epithelial cells with human MSC. 13 In vitro fusion is not a property equally shared by all cell types. Thus, mesenchymal stem cells (MSCs) and long term marrow culture cells are more susceptible to fusion than CD34 + cells. Although co-culture is an established method to support the survival of fragile cell populations, fusion has not been observed as an obvious mechanism before. This may well be because the mechanism of fusion was not at the center of these studies and can easily remain undetected if cell identity is determined by a limited marker set. Generally, many of the early studies in the plasticity field relied on surface markers, immunohistochemistry or RT-PCR of donor origin to ascertain cell fate. While expression of lineage-specific genes is clearly a sign of lineage commitment, these expression patterns can well be transient or an artifact of the experimental procedure. Furthermore, usually no evaluation of host markers was performed on the target cells, and no analysis of genomic DNA to exclude fusion was carried out.
An example of in vivo fusion was shown in the brain. When GFP + bone marrow was transplanted into normal hosts, green Purkinje neurons could be found in the brain.
14 Purkinje neurons are mononucleated diploid cells that constitute the only efferent connection from the cerebellum to other brain regions. Each Purkinje neuron can receive over one million inputs from other neurons and a lack of Purkinje neurons results in ataxias. Close 14 (c) Bone marrow transplantation leads to repopulation of the liver of FAH À/À mice with cells of apparent donor origin rescuing the fatal liver defect. However, these cells are generated by fusion proven by aberrant number of sex chromosomes. 16 (FISH: Y red, X green). (d) MAPCs, derived from mice expressing blactamase in all tissues, were injected into murine blastocysts. Whole-body sections of the resulting adult chimeras were stained with X-Gal to reveal cells of donor origin and widespread tissue contribution was detected. 3 (top, control; bottom, injected). This is a composite figure from Jiang et al, 3 LaBarge and Blau, 7 Weimann et al, 14 Wang et al 16 with permission from the authors.
Gene therapy progress and prospects K Kashofer and D Bonnet inspection of the GFP + Purkinje neurons revealed that these were not generated de novo, but had acquired the GFP gene by fusion of a bone marrow-derived cell with a resident Purkinje neuron. The fusion of the two cells gives rise to stable heterokaryons and the morphology of the bone marrow-derived nucleus changes to a typical Purkinje neuron nucleus over time (Figure 2b) . GFP expression could only be found in these specialized neurons, indicating a predisposition to fusion in the Purkinje neurons. A similar study by Alvarez-Dolado et al 15 further strengthens the notion of gradual loss of donor genes. The authors transplanted donor cells, which express GFP and Cre recombinase, into a reporter mouse strain harboring a LacZ gene with a stop codon before it. After a fusion event, the Cre recombinase excises the stop codon and the resulting hybrids are GFP positive and express LacZ. Fusion could be detected in Purkinje neurons, hepatocytes and cardiomyocytes. Cells expressing LacZ but not GFP could be found in increasing amounts as time progressed, indicating that the donor genome was successively silenced or lost. In the fumarylacetoacetate hydrolase knockout (FAH À/À ) mouse model of hereditary tyrosinemia, functional rescue from a lethal genetic disease could be achieved by bone marrow transplantation. 2 Hepatocytes derived from the donor bone marrow contributed approximately 65% of the final recipient liver after serial hepatocyte transplantation, but the percentage of original karyotype was only 30% by Southern blotting, inconsistent with simple transdifferentiation. 16 Analysis of metaphase spreads of these cells revealed that more than 30% of cells had a karyotype consistent with fusion of a diploid donor cell with a diploid or tetraploid host cell ( Figure  2c ). Additionally, many cells displayed aberrant numbers of chromosomes and 94% had a Y chromosome, which was not present in the original marrow donor. Analysis of viral integration sites established that these hepatocytes were derived from a clonal cell population also present in the bone marrow of the recipient mice. 17 Camargo et al 18 demonstrated that the bone marrowderived fusion partner had, once in its development, activated the lysozyme-M promoter, which is thought to be active only in the monomyelocytic lineage. Common myeloid progenitor cells, which lack self-renewal capacity but give rise to a burst of differentiated myelomonocytic cells, were also able to create hepatocytes by fusion, as were mature macrophages derived in vitro from bone marrow. 19 It can be concluded that in the FAH À/À model of damage and repair, fusion of macrophages with resident hepatocytes is the cause of recovery from metabolic disease. The absence of fusion in early stages of development, when macrophages are not yet present in the fetal liver, further strengthens this observation. 20 Not all conversion of bone marrow to other cell types is the result of fusion
As discussed earlier, a highly purified hematopoietic stem cell could be induced to a hepatocyte phenotype by factors released from damaged liver tissue. 5 Analysis of the sex chromosomes of many donor-derived cells did not reveal any other genetic composition except the ones expected from multinucleated liver cells. The speed of integration (few days), the extent (up to 4.5%) and the genomic stability of the cells in this experimental setup make this study very promising. 5 Almeida-Porada et al 21 used transplantation into a preimmune sheep fetus, which has several advantages: the cells are introduced into an environment where all the organs have differentiated but still need to grow exponentially, and where the lack of a native immune system allows engraftment without the usual conditioning regimens necessary in other models. Hematopoietic and mesenchymal stem cells from various sources have been shown to populate the bone marrow and other organs of the sheep in this model. Human lineage negative cells from either adult bone marrow or cord blood were transplanted into fetal sheep and contributed 2-4% to the bone marrow. Analysis of the livers of these animals revealed many hepatocytes of human origin staining positive for human hepatocyte antigen (HEPAR-1) and human albumin but negative for CD45. Analysis of serum revealed secreted human albumin, and genomic probes for humans and sheep failed to detect evidence of fusion. 22 Bone marrow transplantation in the mouse also leads to engraftment in the stem cell compartment of the skin. Bone marrow-derived cells, identified by GFP staining could be detected in the CD34-positive bulge region of hair follicles, in the interfollicular epidermis and the sebaceous glands. 23 When the skin was injured by fullthickness cutaneous wounds an increase in contribution from 7 to 11% could be achieved. In a male-to-male transplant, all GFP-positive cells had only one Y chromosome, indicating that transdifferentiation and not fusion had taken place.
Another way to probe for fusion events in vivo utilizes the Cre-Lox system. 24 When bone marrow cells of a reporter strain harboring a stop-floxed GFP gene are introduced into a host expressing intracellular Cre recombinase, any cells arising from fusion will excise the stop codon before the GFP coding region and become GFP positive. Tissues of recipients were analyzed 8 and 12 weeks after transplantation for BM-derived (Y-chromosome positive) epithelial cells and GFP expression. FACS analysis of single-cell suspensions of lung tissue revealed that donor cells contribute 0.6% of cytokeratin-positive cells. None of these cells were positive for GFP, and all had normal autosome content; thus, they could not have been created by fusion. Y-chromosome-containing cytokeratin-positive hepatocytes were identified in all experimental animals at levels close to 0.05%. None of these cells were GFP-positive. Analysis of the skin revealed up to 0.1% of donor-origin keratinocytes, again without any fusion events. RT-PCR failed to detect any GFP transcript from the muscles of transplanted animals. However, when the muscle tissue was damaged by injection of the snake toxin notexin, GFP transcript was detected in the damaged tissue but not in the contralateral uninjured muscle. The toxin also leads to necrosis of the liver and two GFP positive hepatocytes could be found. In the experimental settings presented here, the profound damage induced by a potent toxin seems to promote fusion events, while a nondamaged environment is permissive for transdifferentiation.
BM cells harboring a stop-floxed GFP gene and Cre under the insulin promoter (INS2) which leads to GFP expression in cells activating the insulin promoter, were transplanted into wild-type mice by Ianus et al. 
Cells with properties similar to ES cells reside in adult tissues
Jiang et al 3 purified a cell population from mouse bone marrow which is viable for more than 120 population doublings in vitro. These cells termed multipotent adult progenitor cells (MAPCs) express markers of ES cells such as Rex1 and Oct4. Consistent with this ES marker expression these cells could contribute to many adult tissues after injection into a blastocyst (Figure 2d ). Clonal populations of these cells were established and could be differentiated into mesodermal endothelium by vascular endothelial growth factor (VEGF-b) and into neuronal lineages by basic fibroblast growth factor (bFGF). Endodermal cell types induced by FGF-4 and HGF showed functional characteristics of hepatocytes. These differentiated cells express the early hepatocytic markers HNF-1a, HNF-3b and GATA4 after 4 days, and the late hepatic markers CK18 and albumin after 14 days. A convincing demonstration of the functionality of the cells was provided by six different assays measuring urea production and secretion, albumin production, cytochrome activity, LDL uptake and gluconeogenesis. Remarkably, MAPCs that differentiated to the hepatic lineage produced levels of albumin similar to those seen in monolayer cultures of primary rat hepatocytes. 26 When murine MAPCs were cultured with a series of growth factors specific for the neuronal lineage, a mature neuronal phenotype emerged. 27 Thorough analysis revealed that 25% of the cells expressed markers of dopaminergic neurons, 18% expressed markers of serotonergic neurons and 52% expressed markers of GABAnergic neurons. Coculture of these cells with primary mouse astrocytes further matured the cell and led to a more elaborate array of axons. In a series of patch-clamp recordings the authors showed occurrence of spiking behavior that can be attributed to voltagegated sodium channels and also suggested the occurrence of synaptic events.
The fact that MAPCs can be efficiently transduced with retroviral vectors underlines their potential applicability for clinical purposes. However, the current isolation procedure involves extensive culture and replating to enrich for MAPCs which could be prohibitively slow for clinical application, underlining the importance of devising new methods for direct isolation of MAPCs. Stem cells similar to ES cells seem to be retained in multiple tissues, as evidenced by the fact that MAPCs can be isolated from bone marrow, muscle or brain. A cell population with similar potential has been isolated by Fernandes 31 suggests a different model to explain the plasticity phenomena seen in many experiments. Cells that express CXCR4 and were isolated from bone marrow by their migration towards the CXCR4 ligand SDF-1 seemed to display properties consistent with a tissue-committed stem cell (TCSC) phenotype. 32 Markers usually associated with tissue stem cells from muscle, neuronal tissue, liver, cardiac tissue and pancreas are expressed in TCSC. Also, interestingly, markers usually found in more primitive cells, like Oct4, Nanog and Rex1, are present. These cells are similar to hematopoietic stem cells with respect to their surface markers, which may mean that they copurify in the extraction protocols for HSC used by other researchers. As upregulation of SDF-1 is a common feature of the damage done in transdifferentiation experiments, it could, therefore, play a role in recruiting these stem cells to the site of damage. 33 Ratajczak et al propose that the bone marrow is not only the niche for HSC, but also a reservoir for already predifferentiated nonhematopoietic CXCR4 + tissue committed stem cells. Specific tissue stem cells isolated from bone marrow or from peripheral blood would be ideal candidates for cell replacement therapies.
Prospects
Several different mechanisms that could explain stem cell plasticity have been discussed so far. The mechanism by which cellular plasticity is achieved will have a profound impact on the potential clinical use of these cells. If stem cells are to be used directly to regenerate damaged tissues, the issue of fusion is of serious concern. As shown in the FAH À/À model, fusion can create therapeutically active cells without an overt downside. Thus, the heterokaryons shown in the liver and brain of experimental mice do not seem to produce a detrimental effect, and have to date not given rise to tumors. However, as the time spans studied are still only a small fraction of the total lifetime of the animals, final conclusions cannot be drawn. If a clinical application accepts fusion as a way of delivering therapeutic genetic material into cells, then the consequences of fusion need to be studied in more detail.
Culture of primary cells is difficult and successful culture and expansion of multipotent stem cells has not yet been achieved. Generating multipotent cell lines would allow for genetic manipulation of these cells. Earlier gene therapy applications were hindered by the inability to screen transduced cells for integration into known oncogenic sites, mainly because of the inability to Gene therapy progress and prospects K Kashofer and D Bonnet culture the cells. If a clonal population of cells can be derived after transduction, the problems of untargeted virus insertion could be overcome. Thorough screening of the insertion site and elimination of cells with multiple hits, or without transgene expression would greatly improve the safety of this approach. This would also allow for screening of cells that give high expression levels of a transgene, as silencing or lack of activation of genes might be a further stumbling stone for this nascent gene therapy approach.
If the damage done to the organ of interest in the patient is not genetic in nature, then the generation of tissue stem cells in vitro would be another promising approach. Autologous transplantation would not only remove the need to find suitable donors, but would also eliminate the problem of immunological incompatibility. To achieve this, a better understanding of the mechanisms of transdifferentiation and of the molecules involved needs to be achieved.
Conclusion
Although the optimism felt in the field a few years ago has largely faded, stem cell therapy is still of high interest. MAPC represent a stem cell population that can be expanded in culture, making them a promising tool in gene therapy. Despite fusion being a possible mechanism of cell fate change, it is not the mechanism behind all plasticity and its effects are still unknown. Using fusion as a therapeutic tool, enhancing engraftment without fusion and identification of tissue stem cells are just a few of the directions to be addressed in the years to come.
